Edition:
India

Deena Beasley

Gilead questions WHO study that cast doubts on drug's COVID-19 benefits

16 Oct 2020

Gilead Sciences Inc has questioned the findings of a World Health Organization (WHO) study that concluded its COVID-19 drug remdesivir does not help patients who have been admitted to hospital.

Analysis: Sales of first big COVID-19 drug, remdesivir, may disappoint

16 Oct 2020

Investors betting on big profits from COVID-19 treatments may get an unwelcome surprise when Gilead Sciences Inc reports quarterly results this month. Its remdesivir, the first important coronavirus treatment, has not been used as much as first expected and faces complex insurance reimbursement issues. | Video

Regeneron's drug becomes first FDA-approved Ebola virus treatment

15 Oct 2020

The U.S. Food and Drug Administration on Wednesday approved Regeneron Pharmaceuticals' triple antibody cocktail as the first Ebola virus treatment, lending validation to similar drugs being developed for COVID-19.

Regeneron antibodies in demand after Trump treatment, doctors seek more data

08 Oct 2020

Patients are asking to join clinical trials of antibody-based COVID-19 drugs after U.S. President Donald Trump was treated last week with an experimental therapy from Regeneron Pharmaceuticals Inc , and on Wednesday he promised to make it free to Americans while touting its benefits.

Regeneron antibodies in demand after Trump treatment, doctors seek more data

08 Oct 2020

Oct 7 Patients are asking to join clinical trials of antibody-based COVID-19 drugs after U.S. President Donald Trump was treated last week with an experimental therapy from Regeneron Pharmaceuticals Inc, and on Wednesday he promised to make it free to Americans while touting its benefits.

Receiving top care, Trump says Americans are learning to live with COVID-19

06 Oct 2020

WASHINGTON U.S. President Donald Trump on Tuesday said Americans were learning to live with COVID-19, a day after returning from hospital to the White House where he will receive intensive treatment for coronavirus unavailable to most people. | Video

Trump faces backlash for removing mask on return to White House

06 Oct 2020

WASHINGTON, Oct 6 U.S. President Donald Trump faced a fresh backlash on Tuesday for removing his mask when he returned to the White House and urging Americans not to fear the COVID-19 disease that has killed more than 209,000 people in the country and put him in hospital.

Trump steroid treatment for COVID-19 raises potential side effect risk

06 Oct 2020

U.S. President Donald Trump is being treated for COVID-19 with a steroid that is recommended for severe cases of the illness and that comes with risks of serious side effects, including mood swings, aggression and confusion.

Trump steroid treatment for COVID-19 raises potential side effect risk

06 Oct 2020

U.S. President Donald Trump is being treated for COVID-19 with a steroid that is recommended for severe cases of the illness and that comes with risks of serious side effects, including mood swings, aggression and confusion.

World News